Albireo to Present at 2020 Jefferies Virtual Healthcare Conference
BOSTON, May 26, 2020 (GLOBE NEWSWIRE) — Albireo Pharma, Inc. (Nasdaq: ALBO), a clinical-stage orphan pediatric liver disease company developing novel […]
AnPac Bio Continues to Build Strong Patent Portfolio, with 3rd Patent Granted This Year in the United States
SAN JOSE, Calif., May 26, 2020 (GLOBE NEWSWIRE) — AnPac Bio-Medical Science Co., Ltd. (“AnPac Bio,” the “Company” or “we”) […]
Lightbridge Receives Australian Patent for Innovative Nuclear Fuel Assemblies
RESTON, Va., May 26, 2020 (GLOBE NEWSWIRE) — Lightbridge Corporation (NASDAQ: LTBR), an advanced nuclear fuel technology company, today announced […]
Asia-Africa-Europe-1 Consortium Deploys Infinera to Double Capacity on Intercontinental Cable System
SUNNYVALE, Calif., May 26, 2020 (GLOBE NEWSWIRE) — Infinera (NASDAQ: INFN) announced today that Asia-Africa-Europe-1 Consortium (AAE-1), one of the […]
miRagen to Present at the Jefferies 2020 Virtual Global Healthcare Conference
BOULDER, Colo., May 26, 2020 (GLOBE NEWSWIRE) — miRagen Therapeutics, Inc. (NASDAQ: MGEN), a clinical-stage biopharmaceutical company focused on the […]
Cellectar Receives FDA Fast Track Designation for CLR 131 in Lymphoplasmacytic Lymphoma/Waldenstrom’s Macroglobulinemia
FLORHAM PARK, N.J., May 26, 2020 (GLOBE NEWSWIRE) — Cellectar Biosciences, Inc. (NASDAQ: CLRB), a clinical-stage biopharmaceutical company focused on […]
Benefitfocus Announces $80 Million Investment by BuildGroup LLC
CHARLESTON, S.C., May 26, 2020 (GLOBE NEWSWIRE) — Benefitfocus, Inc. (NASDAQ: BNFT), the technology platform driving rapid innovation for employers, […]
ContraFect Corporation Announces Private Placement of Common Stock and Warrants to Pfizer Inc.
YONKERS, N.Y., May 26, 2020 (GLOBE NEWSWIRE) — ContraFect Corporation (Nasdaq: CFRX), a clinical-stage biotechnology company focused on discovering and […]
HOOKIPA Pharma to Present at Jefferies Virtual Healthcare Conference
NEW YORK and VIENNA, Austria, May 26, 2020 (GLOBE NEWSWIRE) — HOOKIPA Pharma Inc. (NASDAQ: HOOK, ‘HOOKIPA’), a company developing […]
Viela Bio Announces Proposed Public Offering of Common Stock
GAITHERSBURG, Md., May 26, 2020 (GLOBE NEWSWIRE) — Viela Bio, Inc. (Nasdaq:VIE), a clinical-stage biotechnology company pioneering treatments for autoimmune […]
